369 related articles for article (PubMed ID: 26220650)
1. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.
Jóhannsdóttir S; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2015 Sep; 493(1-2):86-95. PubMed ID: 26220650
[TBL] [Abstract][Full Text] [Related]
2. Formulations and toxicologic in vivo studies of aqueous cyclosporin A eye drops with cyclodextrin nanoparticles.
Jóhannsdóttir S; Kristinsson JK; Fülöp Z; Ásgrímsdóttir G; Stefánsson E; Loftsson T
Int J Pharm; 2017 Aug; 529(1-2):486-490. PubMed ID: 28720540
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B.
Jansook P; Pichayakorn W; Muankaew C; Loftsson T
Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786
[TBL] [Abstract][Full Text] [Related]
4. gammaCD/HPgammaCD: synergistic solubilization.
Jansook P; Loftsson T
Int J Pharm; 2008 Nov; 363(1-2):217-9. PubMed ID: 18691643
[TBL] [Abstract][Full Text] [Related]
5. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
[TBL] [Abstract][Full Text] [Related]
6. yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension.
Jansook P; Ritthidej GC; Ueda H; Stefánsson E; Loftsson T
J Pharm Pharm Sci; 2010; 13(3):336-50. PubMed ID: 21092707
[TBL] [Abstract][Full Text] [Related]
7. Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops.
Jansook P; Muankaew C; Stefánsson E; Loftsson T
Pharm Dev Technol; 2015; 20(5):626-32. PubMed ID: 24754413
[TBL] [Abstract][Full Text] [Related]
8. Antifungal activity of econazole nitrate/cyclodextrin complex: Effect of pH and formation of complex aggregates.
Jansook P; Prajapati M; Pruksakorn P; Loftsson T
Int J Pharm; 2020 Jan; 574():118896. PubMed ID: 31765779
[TBL] [Abstract][Full Text] [Related]
9. γ-Cyclodextrin.
Saokham P; Loftsson T
Int J Pharm; 2017 Jan; 516(1-2):278-292. PubMed ID: 27989822
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
Loftsson T; Hreinsdóttir D; Stefánsson E
J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
[TBL] [Abstract][Full Text] [Related]
11. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions.
Loftsson T; Saokham P; Sá Couto AR
Int J Pharm; 2019 Apr; 560():228-234. PubMed ID: 30771468
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
Moya-Ortega MD; Alves TF; Alvarez-Lorenzo C; Concheiro A; Stefánsson E; Thorsteinsdóttir M; Loftsson T
Int J Pharm; 2013 Jan; 441(1-2):507-15. PubMed ID: 23149258
[TBL] [Abstract][Full Text] [Related]
14. CDs as solubilizers: effects of excipients and competing drugs.
Jansook P; Loftsson T
Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrins as solubilizers: formation of complex aggregates.
Jansook P; Kurkov SV; Loftsson T
J Pharm Sci; 2010 Feb; 99(2):719-29. PubMed ID: 19670293
[TBL] [Abstract][Full Text] [Related]
17. Self-assembly of cyclodextrin complexes: detection, obstacles and benefits.
Muankaew C; Saokham P; Jansook P; Loftsson T
Pharmazie; 2020 Jul; 75(7):307-312. PubMed ID: 32635971
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
Loftsson T; Stefánsson E
Acta Ophthalmol Scand; 2002 Apr; 80(2):144-50. PubMed ID: 11952479
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Dissolution Behavior of Piperine/Cyclodextrins Inclusion Complexes.
Ezawa T; Inoue Y; Murata I; Takao K; Sugita Y; Kanamoto I
AAPS PharmSciTech; 2018 Feb; 19(2):923-933. PubMed ID: 29071656
[TBL] [Abstract][Full Text] [Related]
20. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
Nagai N; Ito Y; Okamoto N; Shimomura Y
Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
